Table 6.
Summary of Bleeding Index Margin and Papillae scores
Time point | Margin or papillae | Mean Modified Gingival Index (±SD) | |
---|---|---|---|
0.1% o-cymen-5-ol/0.6%ZnCl2 (N = 112) | 0.204% Sodium Fluoride (N = 112) | ||
Pre-Prophy Baseline | Margin | 0.71 ± 0.265 | 0.71 ± 0.252 |
Papillae | 0.55 ± 0.274 | 0.57 ± 0.253 | |
Randomisation | Margin | 0.25 ± 0.114 | 0.25 ± 0.108 |
Papillae | 0.16 ± 0.115 | 0.15 ± 0.106 | |
Week 6* | Margin | 0.34 ± 0.156 | 0.40 ± 0.156 |
Papillae | 0.23 ± 0.142 | 0.30 ± 0.147 | |
Week 12*,** | Margin | 0.17 ± 0.083 | 0.24 ± 0.104 |
Papillae | 0.08 ± 0.073 | 0.16 ± 0.107 |
Between treatment differences based on model-adjusted means were statistically significant (P < 0.0001) for week 6 and week 12 in favour of 0.1%w/w o-cymen-5-ol/ 0.6%w/w zinc chloride (ZnCl2) dentifrice for margin and papillae.
N = 104 and N = 101 were assessed in each group respectively at Week 12.